[Radiofrequency ablation in the therapy of supraventricular and ventricular arrhythmias].
We summarize our experience with RF-ablation in 70 patients with symptomatic tachycardia (38 females and 32 males, age 25-73 years). 19 patients with AV reentry tachycardia in WPW-syndrome, 28 patients with node reentry tachycardia (AVNRT), 10 patients with ventricular tachycardia, 9 patients with atrial fibrillation and 4 patients with atrial flutter were treated. The primary success rate in the whole patient group is 87% and the longterm success rate (up to 1 year) 81%. RF-ablation of tachycardia is a highly effective therapy. The patients are free of symptoms and need no further medication. In patients with AVNRT in WPW-syndrome and ventricular tachycardia (structurally normal heart), RF-ablation is the therapy of choice. 32/70 patients were treated on an outpatient basis.
Klinik im Schachen, Aarau.
H O
HO
Gloor
A
A
Sinan Gürsoy
P
P
Zwicky
D000328:Adult; D000368:Aged; D001281:Atrial Fibrillation / Q000628:therapy; D001282:Atrial Flutter / Q000628:therapy; D017115:Catheter Ablation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000628:therapy; D013617:Tachycardia, Supraventricular / Q000628:therapy*; D017180:Tachycardia, Ventricular / Q000628:therapy*
Radiofrequenzablation zur Therapie von supraventrikulären und ventrikulären Rhythmusstörungen.